Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06402435 ×

NCT06402435

This funder is selected. Its supporting articles are shown below.

NCT064024351

Articles mentioning NCT06402435

1 articles · page 1 of 1

Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial

bmjopen · abstract · 2025-09-10 · 1 matching annotations

93.3%

NCT06402435 Ivonescimab luminal-type breast cancer Hubei Cancer Hospital chemotherapy Immunotherapy neoadjuvant SBRT stereotactic body radiotherapy

…journals and conference presentations.Trial registration number NCT06402435.…